title: Cytokine expression during early and late phase of acute Puumala hantavirus infection.
abstract: BACKGROUND
  Hantaviruses of the family Bunyaviridae are emerging zoonotic pathogens which cause hemorrhagic fever with renal syndrome (HFRS) in the Old World and hantavirus pulmonary syndrome (HPS) in the New World. An immune-mediated pathogenesis is discussed for both syndromes. The aim of our study was to investigate cytokine expression during the course of acute Puumala hantavirus infection.
  
  
  RESULTS
  We retrospectively studied 64 patients hospitalised with acute Puumala hantavirus infection in 2010 during a hantavirus epidemic in Germany. Hantavirus infection was confirmed by positive anti-hantavirus IgG/IgM. Cytokine expression of IL-2, IL-5, IL-6, IL-8, IL-10, IFN-γ, TNF-α and TGF-β1 was analysed by ELISA during the early and late phase of acute hantavirus infection (average 6 and 12 days after onset of symptoms, respectively). A detailed description of the demographic and clinical presentation of severe hantavirus infection requiring hospitalization during the 2010 hantavirus epidemic in Germany is given. Acute hantavirus infection was characterized by significantly elevated levels of IL-2, IL-6, IL-8, TGF-β1 and TNF-α in both early and late phase compared to healthy controls. From early to late phase of disease, IL-6, IL-10 and TNF-α significantly decreased whereas TGF-β1 levels increased. Disease severity characterized by elevated creatinine and low platelet counts was correlated with high pro-inflammatory IL-6 and TNF-α but low immunosuppressive TGF-β1 levels and vice versa .
  
  
  CONCLUSIONS
  High expression of cytokines activating T-lymphocytes, monocytes and macrophages in the early phase of disease supports the hypothesis of an immune-mediated pathogenesis. In the late phase of disease, immunosuppressive TGF-β1 level increase significantly. We suggest that delayed induction of a protective immune mechanism to downregulate a massive early pro-inflammatory immune response might contribute to the pathologies characteristic of human hantavirus infection.
authors.affiliation: Department of Transplantation Immunology, University of Heidelberg, Im Neuenheimer Feld 305, 69120 Heidelberg, Germany.
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Sadeghi
authors.forename: Isabella
authors.initials: I
authors.lastname: Eckerle
authors.forename: Volker
authors.initials: V
authors.lastname: Daniel
authors.forename: Ulrich
authors.initials: U
authors.lastname: Burkhardt
authors.forename: Gerhard
authors.initials: G
authors.lastname: Opelz
authors.forename: Paul
authors.initials: P
authors.lastname: Schnitzler
mesh_terms: D000208:Acute Disease; D000328:Adult; D000818:Animals; D016207:Cytokines / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D018450:Disease Progression; D058872:Epidemics; D005260:Female; D005786:Gene Expression Regulation / Q000276:immunology; D005858:Germany; D006480:Hemorrhagic Fever with Renal Syndrome / Q000453:epidemiology / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D056747:Immunomodulation; D018836:Inflammation Mediators / Q000378:metabolism; D008168:Lung / Q000473:pathology; D008297:Male; D008875:Middle Aged; D029262:Puumala virus / Q000276:immunology* / Q000472:pathogenicity; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D015047:Zoonoses
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators
references.citation: J Clin Virol. 2010 Jul;48(3):159-61
references.pmid: 20308016
references.citation: J Clin Virol. 2011 Mar;50(3):247-8
references.pmid: 21195021
references.citation: J Infect Dis. 1996 Jan;173(1):38-43
references.pmid: 8537680
references.citation: Clin Immunol Immunopathol. 1996 Jan;78(1):47-55
references.pmid: 8599883
references.citation: J Med Virol. 1993 Mar;39(3):200-7
references.pmid: 8096868
references.citation: Microbes Infect. 2008 Aug-Sep;10(10-11):1150-7
references.pmid: 18606242
references.citation: Am J Epidemiol. 1988 Apr;127(4):801-7
references.pmid: 2895579
references.citation: Arch Virol. 2010 Jun;155(6):971-5
references.pmid: 20372945
references.citation: Eur J Clin Microbiol Infect Dis. 2011 May;30(5):685-90
references.pmid: 21234633
references.citation: BMC Infect Dis. 2011 May 23;11:142
references.pmid: 21605369
references.citation: Arch Virol. 2004 Jul;149(7):1279-92
references.pmid: 15221531
references.citation: Clin Chem. 2007 Nov;53(11):1899-905
references.pmid: 17717126
references.citation: J Am Soc Nephrol. 2005 Dec;16(12):3669-79
references.pmid: 16267154
references.citation: Infection. 1992 Sep-Oct;20(5):263-6
references.pmid: 1358824
references.citation: Euro Surveill. 2010 May 20;15(20):
references.pmid: 20504391
references.citation: J Virol. 2002 Jan;76(1):444-9
references.pmid: 11739712
references.citation: Clin Vaccine Immunol. 2006 Dec;13(12):1349-57
references.pmid: 17021245
references.citation: Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):305-13
references.pmid: 7649193
references.citation: J Immunol. 1986 May 15;136(10):3916-20
references.pmid: 2871107
references.citation: Viral Immunol. 2006 Summer;19(3):558-64
references.pmid: 16987073
references.citation: BMC Infect Dis. 2010 May 25;10:132
references.pmid: 20500875
references.citation: Emerg Infect Dis. 2008 May;14(5):850-2
references.pmid: 18439382
references.citation: NDT Plus. 2011 Apr;4(2):130-2
references.pmid: 25984133
references.citation: Lancet Infect Dis. 2003 Oct;3(10):653-61
references.pmid: 14522264
references.citation: Clin Microbiol Rev. 2010 Apr;23(2):412-41
references.pmid: 20375360
references.citation: Virology. 2008 Oct 10;380(1):52-9
references.pmid: 18707748
references.citation: Clin Microbiol Infect. 2011 Mar;17(3):326-30
references.pmid: 21129102
references.citation: Am J Kidney Dis. 2004 May;43(5):809-16
references.pmid: 15112171
references.citation: J Infect Dis. 1999 Feb;179(2):295-302
references.pmid: 9878011
references.citation: Acta Med Croatica. 2003;57(5):407-14
references.pmid: 15011469
references.citation: Nephrol Dial Transplant. 2010 Sep;25(9):2997-3003
references.pmid: 20223893
references.citation: Clin Infect Dis. 1997 Nov;25(5):1084-9
references.pmid: 9402362
references.citation: Immunol Rev. 2008 Oct;225:163-89
references.pmid: 18837782
references.citation: Scand J Infect Dis. 1995;27(5):453-6
references.pmid: 8588134
references.citation: Epidemiol Infect. 2011 Mar;139(3):381-90
references.pmid: 20450527
references.citation: Emerg Infect Dis. 2003 Nov;9(11):1395-401
references.pmid: 14718081
references.citation: J Clin Microbiol. 2007 Sep;45(9):3008-14
references.pmid: 17626170
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15496-501
references.pmid: 17875986
references.citation: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Jul;47(7):661-70
references.pmid: 15254821
references.citation: J Virol. 2011 Oct;85(19):10252-60
references.pmid: 21795350
references.citation: Scand J Infect Dis. 1994;26(1):7-13
references.pmid: 7910705
references.citation: Immunol Lett. 2007 Nov 15;113(2):117-20
references.pmid: 17897725
references.citation: Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15502-7
references.pmid: 17878294
references.citation: Microbes Infect. 2001 Nov;3(13):1129-44
references.pmid: 11709294
references.citation: Nephrol Dial Transplant. 2001 Jul;16(7):1368-73
references.pmid: 11427627